Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: Feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts

European Journal of Cardio-thoracic Surgery

Volumn 42, Issue 1, 2012, Pages 164-172

  Lee, Cheul ^a   Ahn, Hyuk ^b   Kim, Soo Hwan ^b   Choi, Sun Young ^b   Kim, Yong Jin ^b  

^a Sejong General Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Calcification; Glutaraldehyde; Knockout mice; Xenograft

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; CALCIUM; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ALLOANTIBODY; ALPHA 1,3 GALACTOSYLTRANSFERASE, MOUSE; BIOLOGICAL MARKER; FIXATIVE; GALACTOSYLTRANSFERASE; GLUTARALDEHYDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COW; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; T LYMPHOCYTE; XENOGRAFT; ANIMAL; CALCINOSIS; CATTLE; EVALUATION; FEASIBILITY STUDY; GENETICS; GRAFT REJECTION; HISTOLOGY; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; POSTOPERATIVE COMPLICATION; TRANSPLANTATION;

ANIMALS; BIOLOGICAL MARKERS; CALCINOSIS; CATTLE; FEASIBILITY STUDIES; FIXATIVES; GALACTOSYLTRANSFERASES; GLUTARAL; GRAFT REJECTION; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOANTIBODIES; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; PERICARDIUM; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84871699106     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezr260     Document Type: Article

References (25)

1. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005;79: 1072-80.
2. Thiene G, Valente M. Anticalcification strategies to increase bioprosthetic valve durability. J Heart Valve Dis 2011;20:37-44.
3. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation: efficacy and mechanisms. Circulation 1997;95:479-88.
4. Pathak CP, Adams AK, Simpson T, Phillips RE Jr, Moore MA. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential. J Biomed Mater Res 2004;69A:140-4.
5. Trantina-Yates AE, Human P, Zilla P. Detoxification on top of enhanced, diamine-extended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in the sheep model. J Heart Valve Dis 2003;12: 93-101.
6. Lim HG, Kim SH, Choi SY, Kim YJ. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium. Eur J Cardiothorac Surg 2012;41: 383-90.
7. Lee C, Kim SH, Choi SH, Kim YJ. High-concentration glutaraldehyde fixation of bovine pericardium in organic solvent and post-fixation glycine treatment: in vitro material assessment and in vivo anticalcification effect. Eur J Cardiothorac Surg 2011;39:381-7.
8. Human P, Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 2001; 71:S385-8.
9. Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006;114:318-27.
10. Dahm M, Husmann M, Mayer E, Prüfer D, Groh E, Oelert H. Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves. Ann Thorac Surg 1995;60:S348-52.
11. Zilla P, Weissenstein C, Human P, Dower T, von Oppell UO. High glutaraldehyde concentrations mitigate bioprosthetic root calcification in the sheep model. Ann Thorac Surg 2000;70:2091-5.
12. Galili U, Clark MR, Shohet SB, Buehler J, Macher BA. Evolutionary relationship between the natural anti-Gal antibody and the Galα13Gal epitope in primates. Proc Natl Acad Sci USA 1987;84:1369-73.
13. Park CS, Park SS, Choi SY, Yoon SH, Kim WH, Kim YJ. Anti α-Gal immune response following porcine bioprosthesis implantation in children. J Heart Valve Dis 2010;19:124-30.
14. Konakci KZ, Bohle B, Blumer R, Hoetzenecker W, Roth G, Moser B et al. Alpha-GAL on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest 2005;35:17-23.
15. McGregor CG, Carpentier A, Lila N, Logan JS, Byrne GW. Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves. J Thorac Cardiovasc Surg 2011;141:269-75.
16. Pearse MJ, Cowan PJ, Shinkel TA, Chen CG, d'Apice AJ. Anti-xenograft immune responses in alpha 1,3-galactosyltransferase knock-out mice. Subcell Biochem 1999;32:281-310.
17. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002;161:2035-46.
18. Lee C, Park CS, Lee CH, Kwak JG, Kim SJ, Shim WS et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 2011;142:351-8.
19. Stone KR, Walgenbach AW, Abrams JT, Nelson J, Gillett N, Galili U. Porcine and bovine cartilage transplants in cynomolgus monkey. I. A model for chronic xenograft rejection. Transplantation 1997;63: 640-5.
20. Galili U, LaTemple DC, Walgenbach AW, Stone KR. Porcine and bovine cartilage transplants in cynomolgus monkey. II. Changes in anti-Gal response during chronic rejection. Transplantation 1997;63:646-51.
21. Macher BA, Galili U. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 2008;1780:75-88.
22. Gonçalves AC, Griffiths LG, Anthony RV, Orton EC. Decellularization of bovine pericardium for tissue-engineering by targeted removal of xenoantigens. J Heart Valve Dis 2005;14:212-7.
23. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL et al. Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb 1994;14:1480-97.
24. Rajachar RM, Tung E, Truong AQ, Look A, Giachelli CM. Role of carbonic anhydrase II in ectopic calcification. Cardiovasc Pathol 2009;18: 77-82.
25. Pearse MJ, Witort E, Mottram P, Han W, Murray-Seqal L, Romanella M et al. Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection. Transplantation 1998;66:748-54.